The agency said the combination would hurt competition for cancer-detection tests while raising prices.
Source link
FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail
![FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/FTC-Rejects-Illumina039s-7-Billion-Deal-for-Cancer-Test-Developer-Grail-1200x640.jpeg)
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
The agency said the combination would hurt competition for cancer-detection tests while raising prices.
Source link